Vol. 5, Issue 8 (2019)
Identification of Platelet Rich Plasma (PRP) Hair losses Prevent: A Study in Birdem General Hospital, Dhaka, Bangladesh
Author(s): Dr. M Moniruzzaman Khan, Mir Nazrul Islam, Dr. M Atiqullah, Dr. Nura Alam
Abstract: Introduction: Newer method of treatment of alopecia is Platelet Rich Plasma (PRP). Clinicians have begun to inject PRP. PRP is defined as a volume of the plasma fraction of autologous blood with a base line platelet concentration (usually more than 1000000 platelet/µL) 1. Abstract parthenogenesis phalacrosis may be a quite common clinical condition encountered by the dermatologists in their daily observe. Objectives: To assess the Clinical Profile of PRP Prevent Birdem General Hospital, Dhaka, Bangladesh. Settings and design: Observational and interventional study. Methods: The present study was Birdem General Hospital, Dhaka, Bangladesh from 1st July 2018 to December 2018. A complete of thirty cases of clinically diagnosed male patients with parthenogenesis phalacrosis within the age bracket of 15-50 years deep-rooted the topic material for gift study. Elaborated history and clinical examination of cases was done. All the routine investigations were dispensed. Statistical analysis used: information analysis was done by victimization applied math package for social sciences (SPSS) and “paired t test”. Results: A complete of thirty patients was studied. Sizable amount belonged to the age bracket 26-30(36.7%) years and 21-25 years (33.3) severally. Majority are from category a pair of to five, Hamilton Norwood classification of Aga. The case history was positive in nineteen cases (63.3%). Frontal, membrane bone and bone areas were concerned in most variety of patients i.e. in twenty patients (66.7%). The patients according clinical improvement within the kind of hair count, hair thickness, hair density with statistically vital p-value (p-0.00) when a median of 2-3 sessions. Conclusion: In our study of thirty patients, twenty patients showed improvement of varied degrees starting from +1 to +7 in line with Jaeschke scale with vital p-value (p-0.00) when treatment with platelet blood living substance thrombolytic protoplasm living substance made plasma (PRP) primarily based upon that we have a tendency to conclude that platelet made plasma (PRP) is efficacious within the treatment of parthenogenesis phalacrosis.